Developing New Mammalian Gene Expression Systems Using the Infectious cDNA Molecular Clone of the Japanese Encephalitis Virus

  • Yun Sang-Im (Department of Internal Medicine, Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University) ;
  • Choi Yu-Jeong (Department of Internal Medicine, Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University) ;
  • Park Jun-Sun (Department of Internal Medicine, Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University) ;
  • Kim Seok-Yong (Department of Internal Medicine, Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University) ;
  • Lee Young-Min (Department of Internal Medicine, Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University)
  • Published : 2003.05.01

Abstract

Major advances in positive-sense RNA virus research have been facilitated by the development of reverse genetics systems. These systems consist of an infectious cDNA clone that encompasses the genome of the virus in question. This clone is then used as a template for the subsequent synthesis of infectious RNA for the generation of synthetic viruses. However, the construction of infectious cDNA for the Japanese encephalitis virus (JEV) has been repeatedly thwarted by the instability of its cDNA. As JEV is an important human pathogen that causes permanent neuropsychiatric sequelae and even fatal disease, a reliable reverse genetics system for this virus is highly desirable. The availability of this tool would greatly and the development of effective vaccines as well as facilitate studies into the basic biology of the virus, including the molecular mechanisms of viral replication, neurovirulence, and pathogenesis. We have successfully constructed a genetically stable infectious JEV cDNA containing full-length viral RNA genome. Synthetic RNA transcripts generated in vitro from the cDNA were highly infectious upon transfection into susceptible cells, and the cDNA remained stable after it had been propagated in E. coli for 180 generations. Using this infectious JEV cDNA, we have successfully expressed a variety of reporter genes from the full-length genomic and various subgenomic RNAs in vitro transcribed from functional JEV cDNAS. In summary, we have developed a reverse genetics system for JEV that will greatly facilitate the research on this virus in a variety of different fields. It will also be useful as a heterologous gene expression vector and aid the development of a vaccine against JEV.

Keywords